Healthcare AI Startup OpenEvidence Raises Fresh Capital at $12 Bn Valuation
The three-year-old company had previously secured $200 million in funding in October, when it was valued at $6 billion.
OpenEvidence, a healthcare artificial intelligence startup described as “ChatGPT for doctors,” is raising $250 million in equity financing at a valuation of $12 billion.
The three-year-old company had previously secured $200 million in funding in October, when it was valued at $6 billion.
As per the report dated December 12, OpenEvidence currently generates annual recurring revenue of $150 million.
Earlier in 2025, the company raised $75 million in a Series A funding round. In November, OpenEvidence also entered into a partnership with the American College of Cardiology aimed at accelerating the translation of medical research into clinical practice.
Becker’s Hospital Review has reached out to OpenEvidence for comment on the report.
Stay tuned for more such updates on Digital Health News
Follow us
